Concepedia

Amy C. Doty

AC

Statistics

Publications

11

Citations

539

H-Index

10

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

BioSurfaces (United States)

University of Michigan

Center for Drug Evaluation and Research

Quantitative BioSciences

Amy C. Doty is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biomedical engineering, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2011–2021

11

Publications

11

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

Bryce Chiang, Y.C. Kim, Amy C. Doty et al. · Journal of Controlled Release · 2016 · 89 citations · Full text

, , +8

Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres

Amy C. Doty, David G. Weinstein, Keiji Hirota et al. · Journal of Controlled Release · 2017 · 88 citations

, , +4

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 82 citations · Full text

Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation

Keiji Hirota, Amy C. Doty, Rose Ackermann et al. · Journal of Controlled Release · 2016 · 77 citations

, , +11

Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

Hongjun Zhang, K. Liu, Qinglin Pu et al. · ACS Medicinal Chemistry Letters · 2019 · 44 citations · Full text

1–5 of 11